REDWOOD CITY, Calif., Jan. 29, 2018 -- Synthego, a leading provider of genome engineering solutions, announces today the launch of ICE, a powerful new tool named “Inference of CRISPR Edits.” ICE software offers rapid, reproducible analysis of Sanger data, which costs a hundred times less than next-gen sequencing (NGS). ICE is free to use and open source, and the only CRISPR analysis software featuring batch processing of Sanger data.
According to BioInformatics’ 2017 Market for CRISPR/Cas9 Genome Editing Products report, 80 percent of respondents ranked validation of genome editing results the most pressing CRISPR workflow challenge. “Rapid advancement of CRISPR research requires reliable tools that are easy-to-use, cost-effective and deliver trustworthy results,” said Kevin Holden, Ph.D., Head of Synthetic Biology, Synthego. “Our ICE software puts high-quality gene editing analysis in reach for all CRISPR researchers.”
Before the availability of ICE, rapid and affordable analysis of CRISPR editing outcomes was a significant challenge facing researchers. NGS is the gold standard for genome editing analysis. However, NGS cost and turnaround time create significant bottlenecks in the CRISPR workflow. Other methods are fast but lack quality and consistency in their results.
Dr. Holden goes on to say, “ICE is intuitive and provides NGS-quality results in a few seconds using only Sanger sequencing data.”
Featuring an easy-to-use interface, ICE provides insertion and deletion (indel) percentage, indel contributions and total discordance against wild-type sequence data for up to hundreds of samples at a time.
“ICE not only produces reliable indel data compared to the alternative algorithms, but it also generates publication-quality indel spectrums and Sanger traces instantly,” said Dr. Daniel Dever, Research Instructor in the Porteus Lab at Stanford University. “ICE has the potential to become a standard for CRISPR analysis.”
"We built ICE to support our complex analysis needs internally," said Rich Stoner, Ph.D., Chief Science Officer at Synthego. "We're releasing it as a free website and open source tool for the broader CRISPR research community to improve the field's access to fast and consistent edit outcome analyses."
ICE joins Synthego’s growing family of CRISPR software tools and portfolio of CRISPRevolution synthetic guide RNA to provide an end-to-end solution for CRISPR researchers everywhere.
To read “Inference of CRISPR Edits from Sanger Trace Data” published on bioRxiv, please visit https://www.biorxiv.org/content/early/2018/01/20/251082
ICE is free and available at ice.synthego.com.
About Synthego
Synthego is a leading provider of genome engineering solutions. The company's product portfolio includes software and synthetic RNA kits designed for CRISPR genome editing and research. With next-generation informatics and machine learning, Synthego’s vision is to bring precision and automation to genome engineering, enabling rapid and cost-effective research with consistent results for every scientist.
Please visit www.synthego.com for more information.
Media Contact Uproar PR for Synthego Courtney Calderon [email protected]


Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion
Lyft Shares Slide After Weak Q1 Profit Forecast and Surprise 2025 Operating Loss
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Samsung Electronics Shares Jump on HBM4 Mass Production Report
AST SpaceMobile Joins MSCI ACWI Index as Largest New Addition, Boosting Market Visibility
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Samsung Electronics Sees Sustained AI-Driven Demand for Memory Chips Into Next Year
Treasury Wine Estates Shares Surge After U.S. Dispute Settlement and Earnings Upgrade
Ralph Lauren Unveils Elegant Fall 2026 Women’s Collection Ahead of New York Fashion Week
Ancora Holdings Builds $200M Stake in Warner Bros Discovery, Targets Netflix Asset Sale Plan
Amazon Explores AI Content Marketplace With Media Publishers
Macquarie Group Shares Jump as Third-Quarter Trading Conditions Improve Across Key Units
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes
Petrobras Posts Record Oil Exports as Production Surge Fuels Global Expansion 



